Dixons Carphone's CEO appointed as next Boots managing director

The group CEO of electrical and telecommunications company Dixons Carphone has been announced as the next managing director of Boots.

Sebastian_James_Boots.jpg
Sebastian James: I'm very excited to be leading one of the UK’s most iconic, venerable brands

Sebastian James will join the multiple “in the summer”, and will officially take up his role as president and managing director of Boots on September 1, parent company Walgreens Boots Alliance said in a statement last Friday (January 19).

Currently group chief executive of Dixons Carphone – having been chief executive of Dixons Retail from 2012-14 – Mr James has also worked for Synergy Insurance Services, Ink Publishing and Mothercare, according to his LinkedIn profile.

“Deep retail expertise”

Commenting on Mr James's appointment, Walgreens Boots Alliance co-chief operating officer Alex Gourlay said: “We are delighted that Sebastian will join our company at an equally exciting and challenging time for the retail environment in the UK, and for the future development of Boots, a brand synonymous with pharmacy and care.”

His “deep retail expertise will drive significant progress and innovation at Boots”, Mr Gourlay added.

Mr James said he is “very excited…to be offered the privilege of leading Boots, surely one of the UK’s most iconic, venerable and trusted brands”.

“At a time of unprecedented change in both the retail and healthcare markets, to build on the fantastic work that the team have done over the last few years, and to be a part of the next chapter for this great company is an extraordinary opportunity,” he added.

Mr James will replace Elizabeth Fagan, Boots' senior vice president and managing director since June 2016, who will take on the newly-created role of non-executive chairman at the multiple in September.

Sign in or register for free

Latest from News

Patient secures ‘urgent’ leukaemia treatment after Pharmacy First consultation

 
• By 
 • comment

A pharmacist has been hailed as “incredible” after she spotted a patient’s leukaemia red flags during an NHS Pharmacy First Plus consultation.

PDA releases ‘six-step test’ for the next funding contract

 
• By 
 • comment

It assesses whether the next funding contract will support pharmacists, keep patients safe, and offer long-term sustainability.

Assisted dying: Pharmacists’ voices are ‘missing’ from dialogue

 
• By 
 • comment

Experts have long been calling for pharmacists to be able to conscientiously object to taking part in the assisted dying process, but one researcher argues that pharmacists’ voices are “missing” from this dialogue.

More from Multiples